Gastroesophageal Reflux Disease clinical trials at UCSD
2 in progress, 1 open to eligible people
Reflux Band in Laryngopharyngeal Reflux
open to eligible people ages 18-99
This 12 week biomarker targeted double blind randomized controlled trial (RCT) will enroll subjects with salivary pepsin positive laryngopharyngeal reflux (LPR) to assess efficacy of the external upper esophageal sphincter (UES) compression device, also known as the Reflux Band. Subjects will be randomized to one of two arms: control or experimental. Following the 8 week intervention period subjects in both arms will continue in a 4 week unblinded period. The primary hypothesis is that a significantly higher proportion of subjects in the experimental arm will meet the primary endpoint for symptom response, compared to subjects in the control arm.
La Jolla, California
A Post-Approval Study of the LINX® Reflux Management System
Sorry, in progress, not accepting new patients
A Post-Approval Study of the LINX® Reflux Management System in a prospective, multicenter, single-arm study, with patients as their own control to monitor the safety and efficacy of the LINX implant procedure and device in a post-approval environment to supplement existing safety and efficacy data.
San Diego, California and other locations
Our lead scientists for Gastroesophageal Reflux Disease research studies include Rena Yadlapati, MD, MSHS.